The Pharmacy Compounding Advisory Committee (PCAC) met on 23 and 24 July 2026 to consider seven peptides for inclusion on the Section 503A Bulk Drug Substances List
agent de ncrcare: amidon de porumb
(PubMed) Liu LL, Wang LN
Recent studies have shown that GLP-1 medications may offer protective effects far beyond weight loss: Cardiovascular Health: GLP-1s have been shown to reduce the risk of heart attack, stroke, and cardiovascular death in patients with type 2 diabetes and obesity
Research demonstrates that BPC-157 promotes gastric mucosal healing, accelerates the closure of tight junctions in the intestinal epithelium, and counteracts damage from NSAIDs, alcohol, and inflammatory cytokines
GLP 1 receptor agonists addressed multiple aspects of glucose homeostasis by enhancing glucose dependent insulin secretion, suppressing glucagon release, delaying gastric emptying, and promoting satiety